Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes

Abstract

From a health care payer perspective in Denmark, intensive therapy was more cost-effective than conventional treatment. Assuming that patients in both arms were treated in a primary care setting, intensive therapy became dominant (cost- and lifesaving).